Ownership history in 22NW, LP · 10 quarters on record
This page tracks every 13F SEC filing in which 22NW, LP reported a position in PSYCHEMEDICS CORP (PMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | UNCHANGED | 276,034 | — | 0% | 0.43% | $643K | — |
| 2024 Q3 | ADDED | 276,034 | +1,616 | +0.6% | 0.53% | $638K | — |
| 2024 Q2 | UNCHANGED | 274,418 | — | 0% | 0.57% | $664K | — |
| 2024 Q1 | UNCHANGED | 274,418 | — | 0% | 0.69% | $804K | — |
| 2023 Q4 | UNCHANGED | 274,418 | — | 0% | 0.53% | $812K | — |
| 2023 Q3 | ADDED | 274,418 | +198,884 | +263.3% | 0.78% | $1.1M | — |
| 2020 Q4 | REDUCED | 75,534 | -100 | -0.1% | 0.14% | $384K | — |
| 2020 Q3 | REDUCED | 75,634 | -6,102 | -7.5% | 0.17% | $334K | — |
| 2020 Q2 | ADDED | 81,736 | +54,336 | +198.3% | 0.25% | $454K | — |
| 2020 Q1 | INITIATED | 27,400 | — | — | 0.13% | $166K | — |